Paul A. Fitzgerald, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Paul A. Fitzgerald, MD

Clinical Professor, Department of Medicine (Endocrinology), UCSF

paul.fitzgerald@ucsf.edu

Phone: (415) 665-1136 (voice)
Box 1222, UCSF
San Francisco, CA 94143-1222

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Cancer Genetics

Education

Dartmouth College, Hanover, NH, B.A., 1964-1968, Pre-medical
Jefferson Medical College, Philadelphia, PA, M.D., 1968-1972, Medicine
Presbyterian Medical Center and the Hospitals of the University of Colorado, Medical Residency, 1972-1975 Internal Medicine
University of California, San Francisco Fellowship, 1976-1978, Endocrinology


Professional Experience

  • 1973-1984
    Emergency Medicine
  • 1978-1979
    Instructor in Medicine and Attending Physician, University of California, San Francisco
  • 1979-2004
    Endocrinology Clinical Practice, 350 Parnassus Avenue, San Francisco
  • 1979-1987
    Assistant Clinical Professor of Medicine and Attending Physician, University of California, San Francisco
  • 1980-1983
    Attending Physician, San Francisco Public Health Service Hospital
  • 1981-1983
    President, Marin County Chapter, American Diabetes Association and Member, Northern California Affiliate, American Diabetes Association
  • 1987-1998
    Associate Clinical Professor of Medicine and Attending Physician, University of California, San Francisco
  • 1991-1993
    Executive Medical Board, University of California, San Francisco
  • 1992-1995
    National Executive Council, The Endocrine Society
  • 1997-2004
    Clinical Professor of Medicine and Attending Physician, University of California, San Francisco

Honors & Awards

  • 1976
    Diplomate, American Board of Internal Medicine, in Internal Medicine
  • 1979
    Diplomate, American Board of Internal Medicine, in Endocrinology & Metabolism
  • 1990
    Charlotte Baer Memorial Clinical Faculty Award for Outstanding Service to UCSF - University of California, San Francisco
  • 1996
    The Best Doctors in America. Pacific Region 1996-1997. Aiken, South Carolina: Woodward/White
  • 1998
    Areas Outstanding Physician Specialists, in Bay Area Consumer's Checkbook
  • 1999
    Top Docs, in San Francisco Magazine
  • 2001
    Top 500 Doctors, in San Francisco Magazine
  • 2001
    America's Top Doctors 2001. A Castle Connolly Guide. New York, NY: Castle Connolly Medical Ltd
  • 2003
    Best Doctors in the Bay Area. In San Francisco Magazine
  • 2003
    America's Top Doctors 2003. A Castle Connolly Guide. New York, NY: Castle Connolly Medical Ltd.
  • 2004
    Americas Top Doctors 2004. A Castle Connolly Guide. New York, N.Y. Castle Connolly Medical Ltd.

Selected Publications

  1. Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG). Horm Metab Res. 2012 Jun; 44(7):539-42.
    View on PubMed
  2. Metastatic pheochromocytoma and paraganglioma: focus on therapeutics. Horm Metab Res. 2012 May; 44(5):390-9.
    View on PubMed
  3. Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Pediatr Blood Cancer. 2011 Feb; 56(2):191-201.
    View on PubMed
  4. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Ann N Y Acad Sci. 2006 Aug; 1073:465-90.
    View on PubMed
  5. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer. 2003 Jul 15; 98(2):239-48.
    View on PubMed
  6. Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy. Surgery. 2001 Dec; 130(6):1072-7.
    View on PubMed
  7. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1999 Mar; 84(3):930-6.
    View on PubMed
  8. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case. Ann Acad Med Singapore. 1998 Sep; 27(5):712-6.
    View on PubMed
  9. Perils and pitfalls in the diagnosis of Cushing's syndrome. West J Med. 1998 Jul; 169(1):46-50.
    View on PubMed
  10. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest. 1997 Dec; 20(11):648-58.
    View on PubMed
  11. Diabetes insipidus from sarcoidosis confined to the posterior pituitary. Eur J Endocrinol. 1997 Nov; 137(5):514-9.
    View on PubMed
  12. Cushing's syndrome due to bilateral adrenal macronodular hyperplasia with undetectable ACTH: cell culture of adenoma cells on extracellular matrix. Horm Res. 1988; 29(4):162-7.
    View on PubMed
  13. Euthyroid sick or 'hyperthyroid sick'? Hosp Pract (Off Ed). 1987 Oct 30; 22(10A):113, 115-8.
    View on PubMed
  14. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med. 1986 Feb; 104(2):180-6.
    View on PubMed
  15. Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab. 1982 Feb; 54(2):413-22.
    View on PubMed
  16. Cushing's syndrome: problems in management. Endocr Rev. 1982; 3(3):229-44.
    View on PubMed
  17. Fungal infections in Cushing's syndrome. Ann Intern Med. 1981 Sep; 95(3):392.
    View on PubMed
  18. Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature. Am J Med. 1981 Aug; 71(2):302-6.
    View on PubMed
  19. Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing disease and the ectopic ACTH syndrome. Ann Intern Med. 1981 May; 94(5):647-52.
    View on PubMed
  20. Cushing's syndrome: problems in diagnosis. Medicine (Baltimore). 1981 Jan; 60(1):25-35.
    View on PubMed

Go to UCSF Profiles, powered by CTSI